Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

TMO - Thermo Fisher Scientific Inc.... | Finranks

Home

/

TMO

T

Thermo Fisher Scientific Inc. (TMO)

NYQ – Цена в реальном времени. Валюта: USD

602.97

-2.03 (-0.34%)

Рынок открыт: Aug 12, 2026, 3:25 PM EDT

605.94

+0.94 (0.16%)

Предыдущая сессия: Aug 11, 2026, 7:39 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

LUXEMBOURG & NEW YORK & PARIS--(BUSINESS WIRE)--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026. The Microbiology business is a global provider of diagnostic consumables and equipment used.

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing.

Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost

Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost

Thermo Fisher Scientific is eyeing a 15%-20% increase in its customer base in India over the next five years, betting on the growing biopharma research and ‌manufacturing ecosystem, the head of its India unit said.

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

Thermo Fisher Raises 2026 Outlook After Strong Second-Quarter Results

Thermo Fisher Scientific Inc. TMO raised its 2026 outlook after second-quarter earnings and revenues exceeded expectations. The update reflects stronger customer activity, better acquisition performance and improved operating leverage.

Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects

Unlocking Thermo Fisher (TMO) International Revenues: Trends, Surprises, and Prospects

Examine the evolution of Thermo Fisher's (TMO) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Видео

No Data

There is no data to display

Пресс-релизы

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist

LUXEMBOURG & NEW YORK & PARIS--(BUSINESS WIRE)--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026. The Microbiology business is a global provider of diagnostic consumables and equipment used.

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing.